Инфаркт миокарда (ИМ) в течение многих лет является одной из главных причин
инвалидизации и смертности населения во многих экономических развитых странах. В …

Iatrogenic disease is one of the most frequent causes of hospital admissions and constitutes
a growing public health problem. The most common type of iatrogenic neurologic disease is …

Cardiovascular disorder occurs when a local blood clot obstructs an artery or a vein to its
surround organs, causing related tissues to lose function and die. It is one of the leading …

Objective: The objective of this study is to estimate the expected health outcomes, costs and
cost-effectiveness of changing from current practice, where thrombolytic therapy is given in …

Current trends in thrombolysis are of relevance to both diagnostic and interventional
radiologists. In addition to the traditional use of thrombolytic therapy in conditions such as …

Aim: To investigate the thrombolytic and antiplatelet effects of a novel plasminogen activator
from the venom of the Gloydius brevicaudus viper (GBV-PA) in vitro and in vivo. Methods …

To demonstrate thrombolytic efficacy of a tissue plasminogen activator (tPA)-loaded
echogenic liposome (TELIP) formulation in a rabbit thrombotic stroke model (the most …

Cardiovascular drugs are used to treat arterial hypertension, hyperlipidemia, arrhythmias,
heart failure, and coronary artery disease. They also include antiplatelet and anticoagulant …

Objective: This prospective, open-label, randomized study compared the efficacy and safety
of prasugrel and ticagrelor in the Indian patients with acute coronary syndrome (ACS) …

Objective: To evaluate the thrombolytic treatment in acute myocardial infarction (AMI) and to
compare the costs and the effectiveness of Reteplase double-bolus vs Streptokinase in our …